Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Luciano Ibba

IRCCS Humanitas Research Hospital

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Immunology Immunology professors in Italy

Articles (20)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Collaborators (14)

Francesco Bellinato

University of Verona

ITALY

View details

Flavia Manzo Margiotta

University of Pisa

ITALY

View details

Paola Facheris

Dermatologist

IRCCS Humanitas Research Hospital

ITALY

View details

Antonio Costanzo

Full Professor of Dermatology

Humanitas University

ITALY

View details

Francesca Satolli

ITALY

View details

Alessandra Chiei Gallo

University of Milan

ITALY

View details

Andrea Carugno

Assistant Professor (Researcher)

University of Insubria

ITALY

View details

Giuseppe Gallo

Università degli Studi di Torino

ITALY

View details

Arturo Bonometti

Assistant professor

Humanitas University

ITALY

View details

Piergiorgio Malagoli

CHIEF

IRCCS Ospedale San Raffaele

ITALY

View details

Paolo Calzari

University of Milan

ITALY

View details

Dedee F. Murrell

AUSTRALIA

View details

Carmen Cantisani

Prof

Sapienza University of Rome

ITALY

View details

Mario Valenti

Humanitas University

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Luciano Ibba

Research Interests

Explore related searches

Articles (20)

GLP‐1‐based therapy and early response to advanced treatment in atopic dermatitis with obesity

Tildrakizumab in Managing Psoriasis with Involvement of Difficult-to-Treat Areas: A Multicenter Real-Life Retrospective Study

Lebrikizumab After Multiple Prior Advanced Therapies in Moderate‐To‐Severe Atopic Dermatitis: A Real‐World Case Series

Comparative Effectiveness and Safety of Baricitinib and Ritlecitinib in Severe Alopecia Areata: A Real-World Monocentric Retrospective Study

JAK Inhibitor Safety in Atopic Dermatitis and Alopecia Areata: A 4.5-Year Real-World Retrospective Cohort Study

Dose Adjustment of JAK Inhibitors for the Management of Moderate-to-Severe Atopic Dermatitis: A Single-Centre Retrospective Study

Long-Term Disease Control During Continuous Treatment with Upadacitinib and Baricitinib for Moderate-to-Severe Atopic Dermatitis: a Real-World Monocentric Retrospective Study

JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology

Reply to Hagino et al.: ‘Importance of Upadacitinib dose escalation prior to switch to lebrikizumab’

Clearance of Darier disease lesions in a patient with concomitant atopic dermatitis treated with abrocitinib

Baricitinib for the treatment of severe alopecia areata: results from a 52-week multicenter retrospective real-world study

Effectiveness of dupilumab in tralokinumab‐resistant patients with atopic dermatitis: A real‐world experience from two referral centres

Using Biologics to Reduce Long‐Term Corticosteroid Use in Pyoderma Gangrenosum: Real‐World Evidence From Two Centres

Five‐year drug survival of dupilumab in atopic dermatitis: Italian landscape AD real‐world study

Erythroderma in the spectrum of thymoma-associated multiorgan autoimmunity (TAMA) syndrome: a case report of a patient with thymoma and myasthenia gravis

Real-World Effectiveness and Safety of Upadacitinib and Abrocitinib in Moderate-to-Severe Atopic Dermatitis: A 52-Week Retrospective Study

New and Emerging Biologics and Jak Inhibitors for the Treatment of Prurigo Nodularis: A Narrative Review

Real-Life Effectiveness and Safety of Bimekizumab in Plaque Psoriasis Involving Difficult-to-Treat Areas: A 52-Week, Retrospective Real-World, Single-Center Study

Predictors of Super-Responder Status to Anti-IL-23 Therapies in Moderate-to-Severe Plaque Psoriasis: A Real-World Monocenter Study

An updated safety review of Hidradenitis Suppurativa treatment options

Collaborators (14)

Francesco Bellinato

Flavia Manzo Margiotta

Paola Facheris

Antonio Costanzo

Francesca Satolli

Alessandra Chiei Gallo

Andrea Carugno

Giuseppe Gallo

Arturo Bonometti

Piergiorgio Malagoli

Paolo Calzari

Dedee F. Murrell

Carmen Cantisani

Mario Valenti

Make your next move.